In our study, we demonstrated that targeting P4HA1 significantly inhibits CRC growth, metastasis, and TAM infiltration, primarily through the modulation of the P4HA2‐PI3K‐AKT signaling pathway. Here, AKT1 is linked to colorectal carcinoma.